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All reagents were used as received unless otherwise noted. Solvents were purified under nitrogen 
using a solvent purification system (Innovative Technology, inc., Model # SPS-400-3 and PS-
400-3). Bis(cyclooctadiene)nickel(0) (Ni(COD)2), potassium t-butoxide (KO-t-Bu), titanium 
tetrafluoride (TiF4), and silver tetrafluoroborate (AgBF4) were stored and weighed in an inert 
atmosphere glovebox.  O-3,4,6-Tri-O-benzyl β-D-glucosyl fluoride was prepared according to 
the method of Cumpstey et al.1 4-Formyl cyclohexanone was synthesized according to the 
method patented by Hoffman La Roche.2 Aldehydes and alkynes were distilled or purified by 
flash column chromatography immediately before use. Chlorodimethylsilane (98% Aldrich, 
(Me2Si(H)Cl) was distilled under N2 and stored at 0 °C in a Schlenk flask prior to use. Powdered 
3 Å molecular sieves were dried overnight before use at 175 °C at less than 1 torr, pellet (8 
mesh) 3 Å molecular sieves were flame dried under vacuum immediately before use. All 
reactions were performed in flame-dried glassware under a nitrogen atmosphere. 1H and 13C 
spectra were obtained in CDCl3 at rt, unless otherwise noted, on a Varian Mercury 400, Varian 
Unity 500, Varian vnmrs 500 or Varian vnmrs 700 MHz instrument. Chemical shifts of 1H NMR 
spectra were recorded in parts per million (ppm) on the δ scale from an internal standard of 
residual chloroform (7.26 ppm). NMR spectra are described using first order analysis.  Chemical 
shifts of 13C NMR spectra were recorded in ppm from the central peak of CDCl3 (77.16 ppm) on 
the δ scale. High resolution mass spectra (HRMS-ES (m/z)) were obtained via ESI on a VG-70-
250-s spectrometer manufactured by Micromass Corp. (Manchester UK) at the University of 
Michigan Mass Spectrometry Laboratory. 
 
Preparation of Sugar Silane 1b 
In a 25 mL round bottom flask, 3,4,6-tri-O-benzyl β-D-glucosyl fluoride (452 mg, 1.0 mmol) 
was dissolved in dry CH2Cl2 (5 mL, 0.2M) and cooled to 0 °C in an ice bath. Freshly distilled 
NEt3 (280 µL, 2.0 mmol) was added and stirred for 5 min, Me2Si(H)Cl (166 µL, 1.5 mmol) was 
then added. This mixture was allowed to stir for 45 min, then volatiles were removed by rotary 
evaporation, and the resulting oil was extracted from ice cold NaHCO3 (aq) with CH2Cl2. The 
combined organic extracts were dried quickly over MgSO4, filtered, concentrated, and the 
resulting pale yellow oil was dried under high vacuum until complete removal of CH2Cl2 was 
observed by 1H NMR.  Suspension in benzene (~5 mL) and concentration by rotary evaporation 
facilitated removal of trace CH2Cl2.  
Isolated yield 490 mg, 0.96 mmol, 96% yield. 
 
1H-NMR (500 MHz, CDCl3) δ 7.36—7.25 (m, 13H), 7.14—7.10 (m, 2H), 5.06 (dd, J =52.9, 7.0 
Hz, 1H), 4.89 (d, J =11.0 Hz, 1H), 4.82—4.74 (m, 3H), 4.63 (d, J =12.0 Hz, 1H), 4.54 (d, J 
=12.5 Hz, 1H), 4.51 (d, J =11.0 Hz, 1H), 3.77—3.63 (m, 4H), 3.59—2.54 (m, 2H), 0.26 (d, J 
=2.7 Hz, 3H), 0.25 (d, J =2.9 Hz, 3H); 
13C-NMR (125 MHz, CDCl3) δ  138.2, 137.81, 137.79, 128.40, 128.37, 127.91, 127.89, 127.83, 
127.79, 127.72, 127.69, 109.4 (d, J =215 Hz), 84.5 (d, J =11.1 Hz), 76.8, 76.3 (d, J =21.8 Hz), 
75.6, 75.0, 74.8 (J =5.2 Hz), 73.6, 68.2, -1.1, -1.2 (d, J = 2.0Hz)  
IR (cm-1) 1500, 1454, 1363, 1256, 1096, 1062, 899 
HRMS-ES (m/z) [M+Na+] calculated 533.2130 found: 533.2132 
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Preparation of IMCy ligand 
Ligand IMCy was prepared according to the previously reported procedure by Montgomery,3 but 
differed in the final purification.  Following successful formation of the imidazolium salt, triethyl 
orthoformate was removed by concentration under high vacuum at room temperature.  The crude 
residue was then purified by flash column chromatography using a gradient of 3.5:1 hexanes: 
EtOAc to 1:1 hexanes: EtOAc, yielding an oily, pale-yellow foam.  This product was lyophilized 
from frozen benzene to yield a fluffy, white solid, which was dried at 45 °C under high vacuum 
overnight before being transferred to an inert atmosphere glove box for storage prior to use.   
 
General procedure (1) for three-component coupling of an aldehyde, an alkyne and sugar 
silane 1b.   
A solid mixture of Ni(COD)2 (4.2 mg, 0.015 mmol), R,R-IMCy·HBF4 (12.3 mg, 0.015 mmol), 
and KOtBu (1.7 mg, 0.015 mmol) was dissolved in dry THF (0.75 mL) at rt under an inert 
atmosphere of N2.  The solution quickly turned a deep, brick red and was stirred for 30 – 45 min. 
The aldehyde (0.15 mmol, 1.0 equiv) was added directly to the catalyst solution via 
microsyringe.  A solution of sugar silane  (102 mg, 0.2 mmol, 1.3 equiv) and alkyne (0.15 mmol, 
1.0 equiv) in THF (0.75 mL) was added to the catalyst solution over 50 min via a syringe drive. 
At the end of the syringe drive, a second aliquot of alkyne (0.15 mmol, 1.0 equiv) in 0.5 mL dry 
THF was added over 80 min. The reaction was stirred until disappearance of aldehyde was 
clearly observed by TLC or overnight, in the instance of incomplete conversion.  The reaction 
mixture was diluted with an equal volume of hexane and filtered through a short plug of silica 
gel, which was washed with a mixture of EOtAc/hexanes. The solution was concentrated by 
rotary evaporation and the residue was purified via flash chromatography (SiO2) to afford the 
desired product.  Diastereomeric ratios were determined by 19F-NMR analysis of the purified 
reaction mixtures. 
 
General procedure (2) for intramolecular directed glycosylations of glucosyl fluorides. 
Prior to glycosylation, the tethered glucosyl fluoride was azeotropically dried by concentration in 
toluene and stored under high vacuum (at least 8 hrs) prior to use.  The vial was charge with 3 Å 
molecular sieves (pellets, ~ 3 times the mass of sugar) and dry acetonitrile (0.03 M).  The flask 
was then stirred for 45 min to 1 h. 
Concurrently, a round bottom flask was charged with activated powdered 3 Å molecular sieves 
(75 mg/mL of final volume, TiF4 (3 equiv), AgBF4 (1.5 equiv) and a stir bar.  The flask was 
covered in aluminum foil, placed under an inert atmosphere of N2, and cooled to 0 °C in an ice 
bath.  Dry acetonitrile was added (0.05 M with respect to sugar) and the mixture was stirred for 
45 min to 1 h. The vial containing the sugar was cooled to 0 °C, and the sugar solution was 
transferred by cannula onto the heterogeneous catalyst solution at a steady drip.  The reaction 
temperature was maintained between 0-4 °C for 5 h at which point completion of the reaction 
was confirmed by 19F-NMR of an aliquot.  
The reaction mixture was filtered over a pad of Celite onto ice cold NaHCO3 (aq).  Both the 
Celite and aqueous solution were washed with copious EtOAc.  The mixture was filtered over 
celite a second time in the instance of an unbreakable emulsion.  The combined organic layers 
were dried over MgSO4 and concentrated. The oily residue containing the 2-O-SiMe2F analogue 
of the desired product was suspended in THF (0.05 M).  Tetrabutylammonium fluoride (1.5 eq, 
1.0 M in THF) was added and the reaction mixture was stirred until consumption of the 
intermediate was observed by TLC, typically less than 10 min.  Prolonged exposure to TBAF 
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dramatically reduced yields.  The solution was concentrated with silica gel and immediately 
purified by flash column chromatography (SiO2) to afford the desired product as a mixture of 
diastereomers.  Diastereomeric ratios were determined by 1H-NMR analysis of the purified 
reaction mixtures. 
 
3-Component Reductive Couplings 
 
2-O-[(((E)-1-cyclohexylnon-2-en-1-yl)oxy)dimethylsilane]-3,4,6-tri-
O-benzyl- β  -D-glucopyranosyl fluoride (6a) 
 
According to the general procedure 1, freshly distilled cyclohexane 
carboxaldehyde (18 µL, 0.15 mmol), 1-octyne (2 aliquots of 23 µL, 
0.15 mmol each) and sugar silane (102 mg, 0.20 mmol) 1 were stirred 
for 13 h.  The product was obtained by flash chromatography (7:1 hexanes: diethyl ether) as a 
colorless viscous oil of inseparable diastereomers. 19F-NMR analysis of the purified reaction 
mixture indicated a ratio of 5.1: 1 (S:R allylic alcohol stereocenter) diastereomers (79 mg, 0.11 
mmol, 72% yield). 
 
1H-NMR (700 MHz, CDCl3) (major R,R Series) δ 7.36—7.30 (m, 8H), 7.29—7.25 (m, 5H), 
7.11—7.10 (m, 2H), 5.46 (dt, J =15.4, 6.7 Hz, 1H), 5.36 (dd, J =15.4, 7.5 Hz, 1H), 5.10 (dd, J = 
53.1 Hz, J =6.7 Hz), 4.96 (d, J =11.2 Hz, 1H), 4.78 (d, J =11.2 Hz, 1H), 4.77 (d, J =10.7 Hz, 
1H), 4.62 (d, J =12.2 Hz, 1H), 4.54 (d, J =12.2 Hz, 1H), 4.51 (d, J =10.8 Hz, 1H), 3.88—3.82 
(m, 2H), 3.75—2.69 (m, 2H), 3.67 (d, J =9.6 Hz, 1H), 3.62—3.57 (m, 2H), 2.01—1.95 (m, 2H), 
1.81 (d, J =12.5 Hz, 1H), 1.71—1.67 (m, 2H), 1.65—1.61 (m, 2H), 1.36—1.22 (m, 9H), 1.19—
1.05 (m, 3H), 0.91—0.85 (m, 5H), 0.142 (s, 3H), 0.138 (s, 3H); 
13C-NMR (175 MHz, CDCl3) (major R,R series) δ 138.6, 138.1, 138.0, 132.2, 131.6, 128.5, 
128.5, 128.4, 128.1, 128.0, 127.9, 127.9, 127.8, 127.7, 109.5 (d, J =215.3 Hz), 84.7 (d, J =10.2 
Hz), 78.7, 75.3, 75.1, 74.9, 74.8, 74.7, 73.7, 68.6, 44.4, 31.8, 29.4, 29.1, 29.0, 28.9, 28.8, 26.8, 
26.4, 26.3, 22.8, 14.2, -1.1, -1.3  (distinct minor) 132.1, 131.6, 78.7, 28.9, -1.0, -1.6; 
19F-NMR (377 MHz, CDCl3) δ (minor, R,R series) δ  -138.3 (J =53.1, 12.5 Hz); (major, R,R 
series)  -138.5  J =53.5 Hz, 12.6 Hz; 
IR  (cm-1) 1455, 1365, 1359, 1257, 1097, 1067, 873;  
HRMS-ES (m/z)  [M+NH4+] calculated: 750.4560; found: 750.4563. 
 
 
2-O-[(((E)-1-cyclohexylnon-2-en-1-yl)oxy)dimethylsilane]-3,4,6-tri-
O-benzyl- β  -D-glucopyranosyl fluoride (6b) 
 
According to the general procedure 1 using S,S IMCy-HBF4, freshly 
distilled cyclohexane carboxaldehyde (18 µL, 0.15 mmol), 1-octyne ( 2 
aliquots of  23 µL, 0.15 mmol each) and sugar silane (102 mg, 0.20 
mmol) 1 were stirred for 11 h.  The product was obtained by flash chromatography (7:1 hexanes: 
diethyl ether) as colorless viscous oil of inseparable diastereomers. 19F-NMR analysis of the 
purified reaction mixture indicated a ratio of 1:5.1 (S:R allylic alcohol stereocenter) 
diastereomers (75 mg, 0.10 mmol, 69% yield). 
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1H-NMR (700 MHz, CDCl3) (major SS series, minor RR series) δ 7.37—7.25 (m, 13H), 7.12—
7.09 (m, 2H), 5.43 (dt, J = 15.3, 6.8 Hz, 1H), 5.36 (dd, J = 15.4, 7.6 Hz, 1H), 5.11 (dd, J = 53.0, 
6.8 Hz, 1H), 4.95 (d, J = 11.1 Hz, 1H), 4.78 (d, J = 11.2 Hz, 1H), 4.77 (d, J = 10.7 Hz, 1H), 4.62 
(d, J = 12.3 Hz, 1H), 4.54 (d, J = 12.3 Hz, 1H), 4.50 (d, J = 10.7 Hz, 1H), 3.89—3.81 (m, 2H), 
3.76—3.69 (m, 2H), 3.67 (d, J = 9.5 Hz, 1H), 3.62—3.56 (m, 2H), 2.01—1.96 (m, 2H), 1.82 (d, 
J = 10.9 Hz, 1H), 1.71—1.66 (m, 2H), 1.65‚1.58 (m, 2H), 1.36—1.21 (m, 12H), 1.18—1.04 (m, 
3H), 0.91—0.84 (m, 5H), 0.14 (s, 3H), 0.12 (s, 3H); 
13C-NMR (175 MHz, CDCl3) (major SS series, minor RR series) δ 138.7, 138.09, 138.06, 
132.2, 131.7, 128.59, 128.57, 128.5, 128.12, 128.09, 128.0, 127.9, 127.8, 127.7, 109.5 (d, J = 
215.8Hz), 84.8 (d, J = 10.2Hz), 84.75, 78.7, 75.4, 75.1, 75.0, 74.9, 74.8, 68.6, 44.4, 32.4, 31.9, 
29.4, 29.12, 29.09, 28.9, 26.8, 26.40, 26.37, 22.8, 14.3, -0.9, -1.53; 
19F-NMR (470 MHz, CDCl3) (major SS series) δ  -138.3 (J =53.1, 12.5 Hz)  (minor, SS series) 
 -138.5 (J =53.5 Hz, 12.7 Hz); 
IR  (cm-1) 1455, 1365, 1261, 1093, 1067, 977; 
HRMS-ES (m/z)  [M+NH4+] calculated: 750.4560 found: 750.4566. 
 
Stereochemistry determination 
The absolute stereochemistry of the allylic alcohol from 6a was determined by preparing the (S)-
Mosher's ester, which was synthesized from the corresponding alcohol and (R)-Mosher's acid 
chloride. Following Bu4NF deprotection of 6a, the resulting allylic alcohol (38 mg, 0.17 mmol) 
and 42 mg DMAP (0.34 mmol) were dissolved in 0.5 mL of tetrahydrofuran and stirred under 
nitrogen at 20 °C. A solution of (R)-(−)-α-methoxy-α-(trifluoromethyl)phenylacetyl chloride (86 
mg, 0.34 mmol) in 0.46 mL tetrahydrofuran was added dropwise, and the reaction mixture was 
stirred until TLC indicated complete consumption of the starting alcohol. The reaction mixture 
was filtered through a short silica plug with 15% ethyl acetate/85% hexanes and concentrated to 
yield the (S)-Mosher's ester product (67 mg, 89% yield). The observed downfield shift of the 
alkenyl protons in the major isomer indicates that it is has the (S) configuration, which is 
consistent with previous reports using the same catalyst.  
 
2-O-[(((E)-6-cyclohexyl-2-methylhex-4-en-3-yl)oxy) 
dimethylsilane]-3,4,6-tri-O-benzyl- β-D-glucopyranosyl fluoride 
(6c) 
 
 According to the general procedure 1, freshly distilled 
isobutyraldehyde (14 µL, 0.15 mmol), 3-cyclohexyl-1-propyne ( 2 
aliquots of  22 µL, 0.15 mmol each) and sugar silane (102 mg, 0.20 mmol) 1 were stirred for 11 
h.  The product was obtained by flash chromatography (7:1 hexanes: diethyl ether) as colorless 
viscous oil of inseparable diastereomers. 19F-NMR analysis of the purified reaction mixture 
O
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indicated a ratio of 5.7: 1 (S:R allylic alcohol stereocenter) diastereomers (83 mg, 0.12 mmol, 
78% yield). 
 
1H-NMR (700 MHz, CDCl3) (major and minor) δ 7.37—7.30 (m, 8H), 7.28—7.25 (m, 5H), 
7.12—7.10 (m, 2H), 5.48 (dt, J =15.3, 7.1 Hz, 1H), 5.35 (dd, J =15.3, 7.3 Hz, 1H), 5.11 ((minor) 
JHF = 53.1 Hz, J =7.3 Hz), 5.09 ((major) J = 52.9 Hz, J =6.8 Hz), 4.95 (d, J =11.2 Hz, 1H), 4.78 
(d, J =11.2 Hz, 1H), 4.77 (d, J =10.8 Hz, 1H), 4.61 (d, J =12.0 Hz, 1H), 4.53 (d, J =12.0 Hz, 
1H), 4.50 (d, J =10.8 Hz, 1H), 3.90 (t, J =6.7 Hz, 1H), 3.84 (ddd, J =12.4, 8.3, 6.8 Hz, 1H), 
3.74—3.66 (m, 3H), 3.60—3.46 (m, 2H), 1.94—1.84 (m, 2H), 1.70—1.60 (m, 6H), 1.29—1.09 
(m, 4H), 0.92—0.77 (m, 8H), 0.15—0.14 (m, 6H); 
13C-NMR (175 MHz, CDCl3) (major) δ 138.6, 138.1, 138.0, 132.2, 130.8, 128.5, 128.5, 128.4, 
128.0, 127.9, 127.9, 127.8, 127.7, 109.6 (d, J =215.3 Hz), 84.8 (d, J =10.2 Hz), 79.1, 77.0, 75.3, 
75.1, 75.0, 74.9, 74.8, 73.7, 68.6, 40.4, 38.1, 34.6, 33.3, 33.2, 26.7, 26.5, 18.5, 18.2, -1.2, -1.3  
(distinct minor peaks) 132.2, 130.7, 79.1, 26.6, -1.1; 
19F-NMR (377 MHz, CDCl3)  (major) δ -138.4 (J =53.6, 12.5 Hz)  (minor) -138.3 (J =53.6, 
12.5 Hz); 
IR (cm-1) 1451, 1362, 1261, 1108, 1067, 884, 866; 
HRMS-ES (m/z) [M+NH4+] calculated 722.4247: found: 722.4252. 
 
 
2-O-[(((E)-1-cyclohexylnon-1-en-3-yl)oxy)dimethylsilane]-3,4,6-tri-O-
benzyl-β-D-glucopyranosyl fluoride (6d) 
 
According to the general procedure 1, freshly distilled heptanal  ( 21 µL, 
0.15 mmol), cyclohexyl acetylene ( 2 aliquots of  20 µL, 0.15 mmol 
each) and sugar silane (102 mg, 0.20 mmol) 1 were stirred for 10 h.  The 
product was obtained by flash chromatography (7:1 hexanes: diethyl ether) as colorless viscous 
oil of inseparable diastereomers and regioisomers.   19F-NMR analysis of the purified reaction 
mixture indicated a combined ratio of  8.5:1 of the 1,2 olefin to 1,1-substituted olefin (SI-1, not 
fully characterized).  The diastereomeric ratio of the major regioisomer was 4.5:1 (S:R allylic 
alcohol stereocenter) (58 mg, 0.086 mmol, 58% yield). 
 
1H-NMR (500 MHz, CDCl3) (major and minor) δ 7.39—7.24 (m, 13H), 7.15—7.10 (m, 2H), 
5.47 (dd, J =15.4, 6.6 Hz, 1H), 5.33 (dd, J =15.4, 7.2 Hz, 1H), 5.19—5.07 (m, 0.18 H, minor), 
5.11 (dd, 0.82 H, major, JHF = 53.1 Hz, J =6.6 Hz), 4.96 (d, J =11.2 Hz, 1H), 4.79 (d, J =11.1 
Hz, 1H), 4.78 (d, J =10.8 Hz, 1H), 4.63 (d, J =12.2 Hz, 1H), 4.55 (d, J =12.2 Hz, 1H), 4.52 (d, J 
=11.0 Hz, 1H), 4.16 (q, J =7.2 Hz, 1H), 3.89—3.81 (m, 1H), 3.78—3.66 (m, 3H), 3.64—3.57 
(m, 2H), 1.97—1.87 (m, 1H), 1.77—1.60 (m, 5H), 1.55—1.50 (m, 1H), 1.46—1.37 (m, 1H), 
1.36—0.97 (m, 13H), 0.88 (t, J =7.0 Hz, 3H), 0.17 (s, 3H), 0.16 (s, 3H); 
13C-NMR (125 MHz, CDCl3) (major) δ 138.6, 138.1, 138.0, 137.0, 130.6, 128.52, 128.51, 
128.4, 128.1, 128.0, 127.93, 127.85, 127.8, 127.7, 109.5 (d, J =215.5 Hz), 84.8 (d, J =10.0 Hz), 
77.0, 75.4, 75.1, 75.0, 74.9, 74.8, 74.3, 73.7, 68.6, 40.4, 38.4, 38.3, 33.1, 33.0, 32.0, 29.4, 26.3, 
26.2, 25.5, 22.8, 14.3, -1.1, -1.2  (distinct minor peaks) 136.8, 38.2, 27.0, -1.1, -1.7;  
19F-NMR (470 MHz, CDCl3)  δ (major)  -138.7 (dd, J = 47.2, 12.4 Hz) 
     (minor, 1,2 olefin) -138.6 
    (1,1- olefin containing products) -138.0 & -139.5 ; 
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IR (cm-1) 1459, 1350, 1096, 1067, 1031; 
HRMS-ES (m/z)  [M+Na+] calculated: 755.4114 found: 755.4110. 
 
 
2-O-[(((E)-4-ethylundec-3-en-5-y)oxy)dimethylsilane]-3,4,6-tri-O-
benzyl-β-D-glucopyranosyl fluoride (6e) 
 
A solid mixture of Ni(COD)2 (4.2 mg, 0.015 mmol), R,R-IMCy·HBF4 
(12.3 mg, 0.015 mmol), and KOtBu (1.7 mg, 0.015 mmol) was dissolved in 
dry THF (0.5 mL) at rt under an inert atmosphere of N2.  The solution 
quickly turned a deep brick red and was stirred for 45 min. The heptaldehyde (21 µL, 0.15 mmol, 
1.0 equiv) was added directly to the catalyst solution via microsyringe.   A solution of sugar 
silane  (102 mg, 0.2 mmol, 1.3 equiv) and 3-hexyne (26 µL, 0.23 mmol, 1.5 equiv) in THF (1.0 
mL) was added in a dropwise fashion via cannula transfer. The solution was stirred overnight.  
The reaction mixture was diluted with an equal volume of hexane and filtered through a short 
plug of silica gel, which was washed with a mixture of EOAc/hexanes. The filtrate was 
concentrated by rotary evaporation.  The product was obtained by flash chromatography (7:1 
hexanes: diethyl ether) as colorless viscous oil of inseparable diastereomers. 19F-NMR analysis 
of the purified reaction mixture indicated a ratio of  3.7:1 (S:R allylic alcohol stereocenter) 
diastereomers (68 mg, 0.096 mmol, 64% yield). 
 
1H-NMR (500 MHz, CDCl3) (major and minor) δ 7.39—7.24 (m, 13H), 7.14—7.10 (m, 2H), 
5.26 (t, J =7.0 Hz, 1H), 5.12 (dd, J = 53.1, 6.6 Hz, 0.21 H (minor)), 5.11 (dd, J = 53.1, 6.6 Hz, 
0.79 H (major)), 4.97 (d, J =11.0 Hz, 1H), 4.79 (d, J =11.3 Hz, 1H), 4.78 (d, J =10.8 Hz, 1H), 
4.63 (d, J =12.0 Hz, 1H), 4.55 (d, J =12.2 Hz, 1H), 4.52 (d, J =10.8 Hz, 1H), 4.12 (t, J =6.6 Hz, 
1H), 3.89—3.81 (m, 1H), 3.78—3.66 (m, 3H), 3.64—3.57 (m, 2H), 2.08—1.96 (m, 4H), 1.54—
1.45 (m, 2H), 1.33—1.13 (m, 8H), 0.99 (t, J =7.6 Hz, 3H), 0.95 (t, J =7.6 Hz, 3H), 0.88 (t, J 
=7.1 Hz, 3H), 0.14 (s, 6H); 
13C-NMR (125 MHz, CDCl3) (major) δ 141.9, 138.6, 138.1, 138.0, 128.53, 128.52, 128.4, 
128.06, 128.03, 127.9, 127.8, 127.76, 127.73, 127.6, 109.5 (d, J =215.5 Hz), 84.8 (d, J =10.5 
Hz), 78.22, 77.0, 75.3, 75.1, 75.0, 74.8, 74.7, 73.7, 68.6, 36.8, 36.7, 29.4, 26.0, 22.8, 20.8, 19.7, 
14.8, 14.5, 14.2, -1.2, -1.5 distinct minor peaks δ 78.2, 36.8, -1.0, -1.9; 
19F-NMR (470 MHz, CDCl3) δ  major: -138.6, (dd, J = 53, 13 Hz) 
     minor: -138.7,(dd, J  = 53, 12 Hz); 
IR (cm-1) 1459,1369,1261,1112,1096,1063, 873; 
HRMS-ES (m/z)  [M+NH4+] calculated: 724.4403 found: 724.4405. 
 
2-O-[4-((E)-1-((dimethylsilyl)oxy)non-2-en-1-yl)cyclohexanone]-
3,4,6-tri-O-benzyl- β  -D-glucopyranosyl fluoride (6f) 
 
According to the general procedure 1, freshly distilled 4-formyl 
cyclohexanone (19 mg, 0.15 mmol), 1-octyne (2 aliquots of 23 µL, 0.15 
mmol each) and sugar silane (102 mg, 0.20 mmol) were stirred for 15 h.  
The product was obtained by flash chromatography (4:1 hexanes: acetone) as colorless viscous 
oil of inseparable diastereomers. 19F-NMR analysis of the purified reaction mixture indicated a 
ratio of 3.5: 1 (S:R allylic alcohol stereocenter) diastereomers (61 mg, 0.082 mmol, 54% yield). 
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1H-NMR (500 MHz, CDCl3) (major and minor) δ 7.38—7.24 (m, 13H), 7.12—7.08 (m, 2H), 
5.52 (dt, J = 15.2, 6.7 Hz, 1H), 5.37 (dd, J = 14.9, 7.1 Hz, 1H), 5.17—5.02 (m, 1H), 4.94 (d, J = 
11.0 Hz, 1H), 4.81 (d, J = 11.2 Hz, 1H), 4.76 (d, J = 10.5 Hz, 1H), 4.63 (d, J = 12.2 Hz, 1H), 
4.54 (d, J = 12.5 Hz, 1H), 4.52 (d, J = 12.5 Hz, 1H), 4.02 (apparent t, J = 6.8 Hz, 1H), 3.84—
3.78 (m, 1H), 3.76—3.65 (m, 3H), 3.62—2.65 (m, 2H), 2.39—2.30 (m, 2H), 2.29—2.19 (m, 
2H), 2.14—2.06 (m, 1H), 2.05—1.92 (m, 3H), 1.81—1.71 (m, 1H), 1.50—1.20 (m, 10H), 0.88 
(t, J = 6.7 Hz, 3H), 0.16 (s, 3H), 0.15 (s, 3H); 
13C-NMR (125 MHz, CDCl3) (major) δ 212.6, 138.6, 138.0, 138.0, 133.4, 130.8, 128.6, 128.6, 
128.6, 128.1, 128.1, 128.0, 128.0, 127.8, 127.6, 109.6 (d, J = 215.5 Hz), 84.7 (d, J = 10.5 Hz), 
77.1, 77.1, 75.5, 75.2, 75.1, 75.1, 75.0, 74.9, 73.8, 68.5, 42.7, 40.9, 40.8, 32.4, 31.9, 29.4, 29.1, 
28.6, 28.4, 22.8, 14.3, -1.1, -1.2, Peaks have been listed when C-F couplings cannot be 
unambiguously determined. 
19F-NMR (470 MHz, CDCl3) δ  (minor) -139.3 (dd, J = 54.5, 12.5 Hz) 
     (major) = -139.5 (dd, J = 52.9, 12.5 Hz); 
IR (cm-1) 1717, 1455, 1260, 1094, 1065, 1030; 
HRMS-ES (m/z)  [M+NH4+] calculated: 764.4352 found: 764.4352. 
 
 
2-O-[(E)-11-((dimethylsilyl)oxy)-11-cyclohexyl-2-methylundec-9-
en-2-ol]-3,4,6-tri-O-benzyl- β  -D-glucopyranosyl fluoride (6g) 
 
According to the general procedure 1, freshly distilled cyclohexane 
carboxaldehyde (18 µL, 0.15 mmol), 2-methyl-9-decyn-2-ol ( 2 
aliquots of  25 mg, 0.15 mmol each) and sugar silane (102 mg, 0.20 
mmol) were stirred for 13 h.  The product was obtained by flash 
chromatography (6:1 hexanes: acetone) as colorless viscous oil of inseparable diastereomers. 19F-
NMR analysis of the purified reaction mixture indicated a ratio of 5.1: 1 (S:R allylic alcohol 
stereocenter) diastereomers  (74 mg, 0.093 mmol, 62% yield). 
 
1H-NMR (500 MHz, CDCl3) (major and minor) 7.39—7.25 (m, 13H), 7.13—7.09 (m, 2H), 5.47 
(dt, J =15.4, 6.6 Hz, 1H), 5.37 (dd, J =15.4, 7.6 Hz, 1H), 5.12 (dd, 0.15 H (minor), JHF = 53 Hz, 
J =6.6 Hz), 5.10 (dd, 0.85 H (major), JHF = 53.1 Hz, J =6.6 Hz), 4.97 (d, J =11.0 Hz, 1H), 4.79 
(d, J =11.3 Hz, 1H), 4.77 (d, J =10.8 Hz, 1H), 4.62 (d, J =11.9 Hz, 1H), 4.55 (d, J =11.8 Hz, 
1H), 4.52 (d, J =10.8 Hz, 1H), 3.90—3.82 (m, 2H), 3.77—3.66 (m, 3H), 3.64—3.57 (m, 2H), 
2.04—1.95 (m, 2H), 1.82 (broad d, J =11.0 Hz, 1H), 1.74—1.48 (m, 4H), 1.47—1.42 (m, 3H), 
1.38—1.26 (m, 9H), 1.24—1.02 (m, 9H), 0.96—0.83 (m, 2H), 0.15 (s, 3H), 0.145 (s, 3H); 
13C-NMR (125 MHz, CDCl3) (major) δ 138.6, 138.1, 138.0, 132.0, 131.7, 128.52, 128.51, 
128.4, 128.1, 128.0, 127.9, 127.8, 127.7, 127.6, 109.5 (d, J = 215.5 Hz), 84.7 (d, J = 10.5 Hz), 
78.7, 77.0, 75.3, 75.0, 74.87, 74.91, 74.8, 71.1, 73.7, 68.6, 44.1, 32.3, 30.1, 29.4, 29.1, 28.8, 26.8, 
26.4, 26.3, 24.5, -1.2, -1.3, Peaks have been listed when C-F coupling cannot be unambiguously 
determined; (distinct minor) 131.7, 78.6, 77.1, 44.0, 24.3;  
19F- NMR (470 MHz, CDCl3) δ       major: -138.4, (dd, J = 53, 13 Hz)   
minor -138.3 (dd, JHF = 53, 13 Hz); 
IR (cm-1) 1455, 1365, 1257, 1093, 1071, 877; 
HRMS-ES (m/z)  [M+NH4+] calculated: 808.4979 found: 808.4982. 
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2-O-[((E)-7-(((t-butyldimethylsilyl)oxy)-1-cyclohexylhept-2-en-
1-yl)oxy)dimethylsilane]-3,4,6-tri-O-benzyl- β  -D-
glucopyranosyl fluoride (6h) 
 
According to the general procedure 1, freshly distilled cyclohexane 
carboxaldehyde (18 µL, 0.15 mmol), O-t-butyldimethylsilyl-5-
hexyn-1-ol (2 aliquots of 32 mg, 0.15 mmol each) and sugar silane 
(102 mg, 0.20 mmol) were stirred overnight.  The product was obtained by flash chromatography 
(7:1 hexanes: diethyl ether) as colorless viscous oil of inseparable diastereomers. 19F-NMR 
analysis of the purified reaction mixture indicated a ratio of 5.3: 1 (S:R allylic alcohol 
stereocenter) diastereomers (101 mg, 0.12 mmol, 81% yield). 
 
1H-NMR (500 MHz, CDCl3) (major and minor) δ 7.39—7.24 (m, 13H), 7.14—7.10 (m, 2H), 
5.48 (dt, J = 15.4, 6.5 Hz, 1H), 5.38 (dd, J =15.4, 7.6 Hz), 5.19—5.02 (m, 1H), 4.98 (d, J =11.0 
Hz, 1H), 4.79 (d, J =11.3 Hz, 1H), 4.78 (d, J =11.0 Hz, 1H), 4.63 (d, J =12.3 Hz, 1H), 4.55 (d, J 
=12.5 Hz, 1H), 4.52 (d, J =10.8 Hz, 1H), 3.91—3.82 (m, 2h), 3.77—3.67 (m, 3H) 3.64—3.56 
(m, 4H) 2.07—1.96 (m, 2H), 1.83—1.81(m, 1H), 1.74—1.60 (m, 4H), 1.56—1.48 (m, 3H), 
1.43—1.26 (m, 3H), 1.23—1.08(m, 3H), 0.98—0.89 (m, 10H), 0.16 (s, 3H), 0.15 (s, 3H), (0.06, 
s 6H); 
13C-NMR (125 MHz, CDCl3) (major) δ 138.6, 138.1, 138.0, 131.9, 131.8, 128.53, 128.51, 
128.4, 128.05, 128.03, 127.9, 127.84, 127.79, 127.7, 127.6, 109.5 (d, JCF = 215.2 Hz), 84.7 (d, 
JCF = 9.8 Hz), 78.6, 77.0, 75.3, 75.0, 74.93, 74.86, 74.3, 71.7, 73.7, 68.6, 63.2, 44.4, 32.6, 32.1, 
29.1, 28.8, 26.8, 26.4, 26.3, 26.1, 25.7, 18.5, -1.1, -1.3, -5.1, Peaks have been listed when C-F 
coupling cannot be unambiguously determined. 
19F NMR (500 MHz, CDCl3) δ major: -138.4 (dd, J = 53, 12 Hz) 
minor -138.3;  
IR (cm-1) 1459, 1358, 1261, 1101, 1060, 839; 
HRMS-ES (m/z)  [M+NH4+] calculated: 852.5061; found: 852.5064.	  
 
 
2-O-[(E)-methyl-7-((dimethylsilyl)oxy)-7-cyclohexylhept-5-
enoate]- 3,4,6-tri-O-benzyl- β  -D-glucopyranosyl fluoride (6i)  
 
Compound 6i was synthesized in a manner similar to the general 
procedure but utilized higher catalyst loadings. A solid mixture of 
Ni(COD)2 (4.2 mg, 0.015 mmol), R,R-IMCy·HBF4 (12.3 mg, 0.015 
mmol), and KOtBu (1.7 mg, 0.015 mmol) was dissolved in dry THF 
(0.75 mL) at rt under an inert atmosphere of N2.  The solution quickly turned a deep brick red 
and was stirred for 30 – 45 min. Cyclohexanecarboxaldehyde (18 µL, 0.15 mmol, 1.0 equiv) was 
added directly to the catalyst solution via microsyringe.   A solution of sugar silane  (102 mg, 0.2 
mmol, 1.3 equiv) and methyl 5-hexynoate (19 mg, 0.15 mmol, 1.0 equiv) in THF (0.75 mL) was 
added to the catalyst solution over 50 min via a syringe drive. At the end of the syringe drive, a 
solution of Ni(COD)2 (4.2 mg, 0.015 mmol), R,R-IMCy·HBF4 (12.3 mg, 0.015 mmol), and 
KOtBu (1.7 mg, 0.015 mmol) in 0.4 mL dry THF was added to the reaction mixture via cannula 
transfer. Subsequently, a second aliquot of alkyne (19 mg, 0.15 mmol, 1.0 equiv) in 0.5 mL dry 
8
THF was added over 90 min. The reaction was stirred overnight.  The reaction mixture was 
diluted with an equal volume of hexane and filtered through a short plug of silica gel, which was 
washed with a mixture of EOtAc/hexanes. The solution was concentrated by rotary evaporation 
and the residue was purified via flash chromatography (7:1 hexanes: EtOAc) to afford the 
desired product as colorless viscous oil of inseparable diastereomers. 19F-NMR analysis of the 
purified reaction mixture indicated a ratio of 5.0: 1 (S:R allylic alcohol stereocenter) 
diastereomers (82 mg, 0.11 mmol, 73% yield). 
 
1H-NMR (500 MHz, CDCl3) (major and minor) δ 7.39—7.25 (m, 13H), 7.15—7.10 (m, 2H), 
5.50—5.38 (m, 2H), 5.18—5.06 (m, 0.21 H, minor), 5.12 (dd, J = 53.8, 6.8 Hz, 0.79 H, (major)), 
4.97 (d, J =11.2 Hz, 1H), 4.80 (d, J =11.0 Hz, 1H), 4.78 (d, J =11.2 Hz, 1H), 4.63 (d, J =12.2 
Hz, 1H), 4.55 (d, J =12.4 Hz, 1H), 4.53 (d, J =11.0 Hz, 1H), 3.90 (t, J =6.0 Hz, 1H), 3.87—3.80 
(m, 1H), 3.79—3.65 (m, 6H), 3.54—3.56 (m, 2H), 2.30 (t, J =7.6 Hz, 2H), 2.07—2.01 (m, 2H), 
1.81 (br d, J =12.2 Hz, 1H), 1.76—1.60 (m, 6H), 1.40—1.29 (m, 1H), 1.22—1.06 (m, 3H), 
0.98—0.83 (m, 2H), 0.16 (s, 3H), 0.15 (s, 3H); 
13C-NMR (125 MHz, CDCl3) (major) δ 174.1, 138.6, 138.04, 138.00, 132.8, 130.5, 128.51, 
128.49, 128.4, 128.02, 128.01, 127.9, 127.8, 127.7, 127.6, 109.5 (d, J =215.2 Hz), 84.7 (d, J 
=10.3 Hz), 78.4, 77.0, 75.3, 75.02, 74.99, 74.91, 74.87, 74.80, 73.7, 68.5, 51.6, 44.3, 33.5, 31.6, 
29.0, 28.8, 26.7, 26.33, 26.29, 24.6, -1.30, -1.31,  
(distinct minor peaks) 128.5, 128.4, 127.8, 127.7, 78.3, 28.8, -1.1, -1.6; 
19F-NMR (470 MHz, CDCl3)  major δ − 138.8 (dd, J =53, 13 Hz) 
     minor δ − 138. 6 (dd, J =53 Hz, 12 Hz); 
IR (cm-1) 1738, 1455, 1365, 1257, 1097, 1054, 873; 
HRMS-ES (m/z)  [M+NH4+] calculated:  766. 4145 found: 766.4151. 
 
 
2-O-[((2-cyclohexyl-1-phenylallyl)oxy)dimethylsilane]-3,4,6-tri-O-
benzyl- β  -D-glucopyranosyl fluoride (6j) 
 
A solid mixture of Ni(COD)2 (5.5 mg, 0.020 mmol), ±DPIPr·HBF4 (12.6 
mg, 0.020 mmol), and KOtBu (2.2 mg, 0.020 mmol) was dissolved in dry 
THF (0.75 mL) at rt under an inert atmosphere of N2.  The solution was 
stirred for 30 min. Benzaldehyde (21 µL, 0.20 mmol, 1.0 equiv) was added directly to the 
catalyst solution via microsyringe.  A solution of sugar silane  (102 mg, 0.2 mmol, 1.3 equiv) and 
cyclohexylacetylene (40 µL, 0.30 mmol, 1.5 equiv) in THF (0.75 mL) was added to the catalyst 
solution over 30 min via a syringe drive. The reaction was stirred for 5 h after completion of the 
syringe drive addition.  The reaction mixture was diluted with an equal volume of hexane and 
filtered through a short plug of silica gel, which was washed with a mixture of EOAc/hexanes. 
The filtrate was concentrated by rotary evaporation and the residue was purified via flash 
chromatography (SiO2,7:1 hexanes: diethyl ether) to yield a colorless oil (123 mg, 0.17 mmol, 
85% yield, 1:1 ratio of diastereomers by 19F-NMR). 
 
1H-NMR (500 MHz, CDCl3) δ 7.38—7.18 (m, 18H), 7.13—7.08 (m, 2H), 5.30 (s, 0.5H), 5.29 
(s, 0.5H), 5.24 (s, 0.5H), 5.22 (s, 0.5H), 5.07 (dd, J =53.1, 6.8 Hz, 0.5H), 5.03 (dd, J =53.1, 6.8 
Hz, 0.5H), 4.92 (s, 1H), 4.89 (d, J =11.0 Hz, 0.5H), 4.83 (d, J =11.3 Hz, 0.5H), 4.78 (d, J =11.3 
Hz, 0.5H), 4.76 (d, J =10.8 Hz, 0.5H), 4.75 (d, J =10.8 Hz, 0.5H), 4.72 (d, J =11.3 Hz, 0.5H), 
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4.623 (d, J =12.2 Hz, 0.5H), 4.619 (d, J =12.2 Hz, 0.5H), 4.54 (d, J =12.0 Hz, 1H), 4.51 (d, J 
=10.8 Hz, 0.5H), 4.50 (d, J =10.8 Hz, 0.5H), 3.84—8.77 (m, 1H), 3.74—3.69 (m, 2H), 3.67—
3.51 (m, 3H), 1.77—1.49 (m, 6H), 1.21—0.96 (m, 5H), 0.15 (s, 1.5H), 0.14 (s, 1.5H), 0.12 (s, 
1.5H), 0.09 (s, 1.5H). 
13C-NMR (125 MHz, CDCl3) δ  156.9, 156.8, 142.89, 142.87, 138.62, 138.60, 138.10, 138.08, 
128.6, 128.54, 128.50, 128.15, 128.14, 128.11, 128.09, 128.02, 127.9, 127.78, 127.75, 127.72 
127.33, 127.30, 127.2, 127.1, 109.5, (J = 215.2 Hz),108.6, 108.5, 84.7, 84.63, 84.57, 77.4, 77.1, 
75.44, 75.36, 75.14, 75.11, 75.0, 74.8, 73.8, 68.6, 39.7, 39.7, 34.4, 33.4, 33.3, 27.1, 27.0, 26.5, -
1.3, -1.4, -1.6, -1.8, Peaks have been listed when C-F coupling cannot be unambiguously 
determined.  
19F-NMR (470 MHz, CDCl3) δ Diastereomer 1: -138.7 (J= 53 Hz, 13 Hz), Diastereomer 2 
-138.8 (J= 53 Hz, 13 Hz); 
IR (cm-1)1496, 1459, 1373, 2137, 1101, 1067, 1033; 
HRMS-ES (m/z)  [M+NH4+] calculated: 742.3934 found: 742.3937. 
 
Intramolecular Directed Glycosylations 
 
((E)-1-cyclohexylnon-2-en-1-yl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (7a) was 
synthesized according to general procedure 2. 2-O-[(((E)-1-cyclohexylnon-2-en-1-
yl)oxy)dimethylsilane]-3,4,6-tri-O-benzyl- β -D-glucopyranosyl fluoride 6a (60 mg, 0.082 
mmol, 5.1:1 S:R), titanium tetrafluoride ( 31 mg, 0.25 mmol) and silver tetrafluoroborate (24 mg, 
0.12 mmol) were stirred for 5h.  Purification by flash chromatography (7:1 hexanes:acetone) 
yielded the desired product as a colorless oil as a mixture of separable diastereomers.  1H-NMR 
analysis revealed a diastereomeric ratio of 4.5:1 of 7a:7b (42 mg, 0.064 mmol, 78 %). 
 
((E)-1-cyclohexylnon-2-en-1-yl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (7b) was 
synthesized according to general procedure 2. 2-O-[(((E)-1-cyclohexylnon-2-en-1-
yl)oxy)dimethylsilane]-3,4,6-tri-O-benzyl- β -D-glucopyranosyl fluoride 6b (72 mg, 0.10 mmol, 
1:5.1 S:R), titanium tetrafluoride (37 mg, 0.30 mmol) and silver tetrafluoroborate (29 mg, 0.15 
mmol) were stirred for 5 h.  Purification by flash chromatography (7:1 hexanes:acetone) yielded 
the desired product as a colorless oil as a mixture of separable diastereomers.  1H NMR analysis 
revealed a diastereomeric ratio of  1:5.8 of 7a:7b (42 mg, 0.064 mmol, 64 %). 
 
((S,E)-1-cyclohexylnon-2-en-1-yl)-3,4,6-tri-O-benzyl-α-D-
glucopyranoside (7a) 
 
1H-NMR (700 MHz, CDCl3) δ 7.40 (d, J =7.4 Hz, 2H), 7.34—7.25 (m, 
11H), 7.16—7.12 (m, 2H), 5.55 (dt, J =15.3, 6.7 Hz, 1H), 5.36 (ddt, J 
=15.4, 8.6, 1.3 Hz, 1H), 4.97 (d, J =3.8 Hz, 1H), 4.97 (d, J =11.2 Hz, 1H), 
4.84 (d, J =11.2 Hz, 1H), 4.81 (d, J =10.5 Hz, 1H), 4.63 (d, J =12.0 Hz, 1H), 4.48 (d, J =10.6 
Hz, 1H), 4.46 (d, J =12.0 Hz, 1H), 3.82 (dt, J =9.9, 2.5 Hz, 1H), 3.74 (dd, J =10.5, 3.3 Hz, 1H), 
3.73—3.66 (m, 4H), 3.54 (dd, J =10.6, 2.0 Hz, 1H), 2.03—1.93 (m, 3H), 1.80 (d, J =11.2 Hz, 
1H), 1.73 (apparent t, J =13.7 Hz, 2H), 1.67—1.62 (m, 2H), 1.52—1.49 (m, 1H), 1.37—1.08 (m, 
11H), 1.00—0.90 (m, 2H), 0.89 (t, J =7.0 Hz, 3H); 
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13C-NMR (700 MHz, CDCl3) δ 139.0, 138.4, 138.2, 134.0, 129.1, 128.51, 128.48, 128.2, 128.1, 
128.0, 127.84, 127.79, 127.7, 98.7, 85.4, 83.9, 77.5, 75.4, 75.2, 73.73, 73.67, 70.7, 68.3, 32.4, 
31.8, 29.33, 29.30, 29.1, 28.7, 26.7, 26.2, 22.8, 14.2; 
IR (cm-1) 1459, 1365, 1135, 1063, 1030; 
HRMS-ES (m/z) [M+Na+] calculated: 679.3969 found 679.3972. 
 
((R,E)-1-cyclohexylnon-2-en-1-yl)-3,4,6-tri-O-benzyl-α-D-
glucopyranoside (7b) 
 
1H-NMR (700 MHz, CDCl3) δ 7.40 (d, J =7.2 Hz, 2H), 7.35—7.26 (m, 
11H), 7.16—7.14 (m, 2H), 5.61 (dt, J =15.3, 6.9 Hz, 1H), 5.17 (dd, J =15.5, 
9.1 Hz, 1H), 5.00 (d, J =3.3 Hz, 1H), 4.98 (d, J =11.0 Hz, 1H), 4.84 (d, J 
=10.8 Hz, 1H), 4.82 (d, J =10.5 Hz, 1H), 4.65 (d, J =12.0 Hz, 1H), 4.52 (d, J =12.2 Hz, 1H), 
4.50 (d, J =10.7 Hz, 1H), 3.82 (ddd, J =10.0, 3.5, 1.8 Hz, 1H), 3.77 (dd, J =15.5, 9.1 Hz, 1H), 
3.73—3.70 (m, 3H), 3.67 (dd, J =10.6, 1.8 Hz, 1H), 3.63—3.61 (m, 1H), 2.06—2.03 (m, 2H), 
1.99 (d, J =9.4 Hz, 1H), 1.90 (d, J =11.3 Hz, 1H), 1.71 (apparent t, J =13.2 Hz, 2H), 1.67—1.62 
(m, 2H), 1.49—1.43 (m, 1H), 1.39—1.33 (m, 2H), 1.32—1.10 (m, 9H), 0.96—0.85 (m, 5H); 
13C-NMR (175 MHz, CDCl3) δ 139.1, 138.4, 138.2, 137.8, 128.6, 128.54, 128.52, 128.3, 
128.14, 128.06, 127.9, 127.8, 127.7, 127.5, 94.2, 84.2, 81.8, 77.6, 75.5, 75.3, 73.6, 73.2, 70.9, 
68.7, 42.3, 32.5, 31.8, 29.7, 29.3, 29.0, 26.7, 26.2, 26.1, 22.8, 14.2;  
IR (cm-1) 1459, 1354, 1130, 1071, 1000; 
HRMS-ES (m/z) [M+NH4+] calculated: 679.3969, found 679. 3979. 
 
2-((E)-6-cyclohexyl-2-methylhex-4-en-3-yl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (7c) 
was synthesized according to general procedure. 2-O-[(((E)-6-Cyclohexyl-2-methylhex-4-en-3-
yl)oxy)dimethylsilane]-3,4,6-tri-O-benzyl-β-D-glucopyranosyl fluoride (63 mg, 0.089 mmol, 
5.7:1, S:R), titanium tetrafluoride ( 33 mg, 0.27 mmol) and silver tetrafluoroborate (26 mg, 0.13 
mmol) were stirred for 5 h.  Purification by flash chromatography (7:1 hexanes:acetone) yielded 
the desired product as a colorless oil as a mixture of separable diastereomers.  1H-NMR analysis 
revealed a diastereomeric ratio of  6.8:1 (S:R) (35 mg, 0.056 mmol, 63 %). 
 
2-((S,E)-6-cyclohexyl-2-methylhex-4-en-3-yl)-3,4,6-tri-O-benzyl-α-D-
glucopyranoside (7c, entry 1, major diastereomer) 
 
1H-NMR (700 MHz, CDCl3) δ 7.38 (apparent d, J =7.2 Hz, 2H), 7.33—
7.25 (m, 11H), 7.25—7.13 (m, 2H), 5.54 (dt, J =15.3, 7.2 Hz, 1H), 5.34 
(dd, J =15.3, 8.4 Hz, 1H), 4.97 (d, J =3.6 Hz, 1H), 4.95 (d, J =11.2 Hz, 
1H), 4.83 (d, J =11.2 Hz, 1H), 4.81 (d, J =10.7 Hz, 1H), 4.63 (d, J =12.2 
Hz, 1H), 4.48 (d, J =10.7 Hz, 1H), 4.46 (d, J =10.7 Hz, 1H), 3.81 (dt, J =9.9, 2.5 Hz, 1H), 
3.75—3.65 (m, 5H), 3.54 (dd, J =10.6, 2.0 Hz, 1H), 1.98 (d, J =9.5 Hz, 1H), 1.92—1.89 (m, 
1H), 1.86—1.79 (m, 2H), 1.67—1.61 (m, 5H), 1.27—1.08 (m, 4H), 0.92—0.82 (m, 8H); 
13C-NMR (175 MHz, CDCl3) δ 139.0, 138.4, 138.2, 132.8, 129.5, 128.52, 128.50, 128.49, 
128.1, 128.06, 128.04, 127.82, 127.80, 127.73, 98.53, 85.7, 83.9, 77.5, 75.4, 75.2, 73.7, 73.6, 
70.7, 68.4, 40.6, 38.0, 33.4, 33.2, 32.5, 26.7, 26.5, 26.4, 18.8, 18.1; 
IR (cm-1) 1459, 1362, 1142, 1060, 1026; 
HRMS-ES (m/z) [M+Na+] calculated: 651. 3656 found 651.3662. 
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((R,E)-6-cyclohexyl-2-methylhex-4-en-3-yl)-3,4,6-tri-O-benzyl-α-D-
glucopyranoside (entry 1 - minor diastereomer) 
 
1H-NMR (700 MHz, CDCl3) δ 7.40 (apparent d, J =6.9 Hz, 2H), 7.35—
7.30 (m, 6H), 7.30—7.26 (m, 5H), 7.15—7.14 (m, 2H), 5.61 (dt, J =15.4, 
6.9 Hz, 1H), 5.21 (dd, J =15.4, 9.0 Hz, 1H), 4.99 (d, J =3.1 Hz, 1H), 4.97 
(d, J =11.0 Hz, 1H), 4.84 (d, J =11.2 Hz, 1H), 4.82 (d, J =10.8 Hz, 1H), 4.65 (d, J =12.1 Hz, 
1H), 4.50 (d, J =11.9 Hz, 1H), 4.49 (d, J =10.6 Hz, 1H), 3.83 (ddd, J =10.0, 3.4, 2.1 Hz, 1H), 
3.78 (dd, J =10.6, 3.7 Hz, 1H), 3.73—7.69 (m, 3H), 3.67 (dd, J =10.5, 1.9 Hz, 1H), 3.65—3.61 
(m, 3H), 2.10—2.06 (m, 3H), 1.91 (d, J =12.5 Hz, 1H), 1.72 (apparent t, J =13.6 Hz, 2H), 1.64 
(apparent t, J =11.9 Hz, 2H), 1.59—1.55 (m, 2H), 1.49—1.40 (m, 4H), 1.23—1.11 (m, 3H), 
0.94—0.86 (m, 2H); 
13C-NMR (175 MHz, CDCl3) δ 139.0, 138.4, 138.1, 136.3, 128.5, 128.49, 128.15, 128.08, 
128.06, 128.03, 127.9, 127.8, 127.7, 94.4, 84.1, 82.6, 77.0, 75.5, 75.2, 73.6, 73.2, 70.9, 68.6, 
40.6, 37.9, 33.3, 33.2, 32.8, 26.6, 26.4, 19.3, 18.8; 
IR (cm-1)1459, 1358, 1134, 1074, 1033; 
HRMS-ES (m/z) [M+Na+] calculated: 651.3656 found 651.3660. 
 
((E)-1-cyclohexylnon-1-en-3-yl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (7d) 
glucopyranoside was synthesized according to general procedure. 2-O-[(((E)-1-cyclohexylnon-
1-en-3-yl)oxy)dimethylsilane]-3,4,6-tri-O-benzyl- β -D-glucopyranosyl fluoride (43 mg, 0.059 
mmol, 5.1:1 S:R ), titanium tetrafluoride ( 22 mg, 0.17 mmol) and silver tetrafluoroborate (16 
mg, 0.088 mmol) were stirred for 5 h.  Purification by flash chromatography (7:1 
hexanes:acetone) yielded the desired product as a colorless oil as a mixture of separable 
diastereomers.  1H NMR analysis revealed a regiomeric ratio of 12.5:1 (1,2 olefin to 1,1 olefin). 
1H NMR analysis revealed a diastereomeric ratio of 3.2:1 (S:R) of the major regioisomer (22 mg, 
0.034 mmol, 57 %). 
 
 
((S,E)-1-cyclohexylnon-1-en-3-yl)-3,4,6-tri-O-benzyl-α-D-
glucopyranoside (7d, entry 2, major diastereomer) 
 
1H-NMR (700 MHz, CDCl3) δ 7.39 (d, J =7.4 Hz, 2H), 7.34—7.26 (m, 
11H), 7.16—7.14 (m, 2H), 5.53 (dd, J =15.6, 6.5 Hz, 1H), 5.32 (ddd, J 
=15.5, 8.1, 1.2 Hz, 1H), 4.99 (d, J =3.8 Hz, 1H), 4.96 (d, J =11.2 Hz, 1H), 
4.84 (d, J =11.2 Hz, 1H), 4.82 (d, J =10.7 Hz, 1H), 4.63 (d, J =12.2 Hz, 1H), 4.51 (d, J =10.7 
Hz, 1H), 4.49 (d, J =12.2 Hz, 1H), 3.95 (apparent q, J =7.0 Hz, 1H), 3.82 (dt, J =9.9, 2.5 Hz, 
1H), 3.75—3.65 (m, 4H), 3.57 (dd, J =10.6, 2.0 Hz, 1H), 2.02 (d, J =9.3 Hz, 1H), 1.92—1.87 
(m, 1H), 1.72—1.62 (m, 6H), 1.49—1.42 (m, 1H), 1.31—1.19 (m, 10H), 1.17—1.10 (m, 1H), 
1.08—0.98 (m, 2H), 0.88 (t, J =7.0 Hz, 3H); 
13C-NMR (175 MHz, CDCl3) δ 139.0, 138.9, 138.4, 138.2, 128.52, 128.50, 128.2, 128.1, 128.0, 
127.84, 127.80, 127.7, 98.0, 83.9, 80.7, 77.5, 75.4, 75.2, 73.7, 73.5, 70.6, 68.4, 40.4, 35.3, 32.91, 
32.89, 31.9, 29.4, 26.3, 26.14, 26.12, 25.3, 22.7, 14.2; 
IR (cm-1) 1459, 1365, 1127, 1071, 1033, 966; 
HRMS-ES (m/z) [M+Na+] calculated: 679.3969 found 679.3976. 
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((R,E)-1-cyclohexylnon-1-en-3-yl)-3,4,6-tri-O-benzyl-α-D-
glucopyranoside (entry 2, minor diastereomer) 
 
1H-NMR (700 MHz, CDCl3) δ 7.39 (d, J =7.2 Hz, 2H), 7.34—7.25 (m, 
11H), 7.15—7.14 (m, 2H), 5.60 (dd, J =15.6, 6.7 Hz, 1H), 5.14 (ddd, J 
=15.5, 8.7, 0.9 Hz, 1H), 4.98 (d, J =4.1 Hz, 1H), 4.97 (d, J =11.3 Hz, 1H), 
4.83 (d, J =11.2 Hz, 1H), 4.82 (d, J =10.6 Hz, 1H), 4.65 (d, J =12.0 Hz, 
1H), 4.50 (d, J =12.0 Hz, 1H), 4.49 (d, J =10.7 Hz, 1H), 3.97 (app q, J =7.3 Hz, 1H), 3.82—
3.80 (m, 1H), 3.78—3.61 (m, 5H), 2.01 (d, J =9.1 Hz, 1H), 1.99—1.93 (m, 1H), 1.73—1.68 (m, 
4H), 1.65—1.59 (m, 2H), 1.50—1.44 (m, 1H), 1.33—1.23 (m, 10H), 1.18—1.12 (m, 1H), 1.09—
1.03 (m, 2H), 0.87 (t, J =7.0 Hz, 3H); 
13C-NMR (175 MHz, CDCl3) δ 142.4, 139.0, 138.4, 138.2, 128.56, 128.54, 128.1, 128.0, 127.9, 
127.85, 127.81, 127.7, 126.5, 94.5, 84.1, 77.6, 75.5, 75.2, 73.6, 73.1, 70.8, 68.7, 40.6, 35.7, 33.0, 
31.9, 29.3, 26.2, 26.1, 25.7, 22.8, 14.3; 
IR (cm-1)1459, 1354, 1130, 1071, 1000; 
HRMS-ES (m/z) [M+Na+] calculated: 679.3969; found : 679.3974. 
 
((E)-4-ethylundec-3-en-5-yl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (7e) was synthesized 
according to general procedure 2-O-[(((E)-4-ethylundec-3-en-5-y)oxy)dimethylsilane]-3,4,6-tri-
O-benzyl- β -D-glucopyranosyl fluoride (63 mg, 0.089 mmol), titanium tetrafluoride ( 33 mg, 
0.27 mmol) and silver tetrafluoroborate (26 mg, 0.14 mmol) were stirred for 3 h.  Purification by 
flash chromatography (7:1 hexanes: acetone) yielded the desired product as a colorless oil as a 
mixture of separable diastereomers.  1H NMR analysis revealed a diastereomeric ratio of 2.8:1 
(S:R) (23 mg, 0.036 mmol, 41 %). 
 
((S,E)-4-ethylundec-3-en-5-yl)-3,4,6-tri-O-benzyl-α-D-
glucopyranoside (7e, entry 3, major diastereomer) 
 
1H-NMR (700 MHz, CDCl3) δ 7.39 (d, J =4.5 Hz, 2H), 7.34—7.23 (m, 
11H), 7.16—7.13 (m, 2H), 5.31 (t, J =7.2 Hz, 1H), 4.96 (d, J =3.6 Hz, 
1H), 4.95 (d, J =11.2 Hz, 1H), 4.83 (d, J =11.2 Hz, 1H), 4.81 (d, J =10.9 
Hz, 1H), 4.62 (d, J =12.3 Hz, 1H), 4.48 (d, J =10.7 Hz, 1H), 4.46 (d, J =12.1 Hz, 1H), 3.90 (t, J 
=6.9 Hz, 1H), 3.77—3.62 (m, 5H), 3.55—3.52 (m, 1H), 2.07—1.97 (m, 5H), 1.67—1.61 (m, 
1H), 1.54—1.49 (m, 1H), 1.31—1.17 (m, 8H), 0.98 (t, J =7.6 Hz, 3H), 0.94 (t, J =7.5 Hz, 3H), 
0.88 (t, J =7.2 Hz, 3H); 
13C-NMR (175 MHz, CDCl3) δ 139.7, 139.0, 138.5, 138.1, 130.7, 128.52, 128.49, 128.47, 
128.09, 128.08, 128.04, 127.81, 127.79, 127.7, 98.0, 84.6, 83.9, 77.5, 75.4, 75.1, 73.6, 73.5, 70.9, 
68.4, 33.5, 31.9, 29.4, 25.8, 22.8, 20.9, 20.2, 14.7, 14.5, 14.2; 
IR (cm-1) 1503, 1455, 1369, 1130, 1071, 1062, 1033, 914; 
HRMS-ES (m/z) [M+NH4+] calculated: 648.4259 found: 648.4258. 
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((R,E)-4-ethylundec-3-en-5-yl)-3,4,6-tri-O-benzyl-α-D-
glucopyranoside (entry 3, minor diastereomer) 
 
1H-NMR (700 MHz, CDCl3) δ 7.39 (d, J =7.1 Hz, 2H), 7.35—7.25 (m, 
11H), 7.17—7.14 (m, 2H), 5.36 (t, J =7.2 Hz, 1H), 4.97 (d, J =11.1 Hz, 
1H), 4.89 (d, J =3.9 Hz, 1H), 4.84 (d, J =11.1 Hz, 1H), 4.82 (d, J =10.7 
Hz, 1H), 4.65 (d, J =12.1 Hz, 1H), 4.51 (d, J =12.1 Hz, 1H), 4.50 (d, J =10.7 Hz, 1H), 3.96 (t, J 
=7.0 Hz, 1H), 3.82—3.79 (m, 1H), 3.78—3.60 (m, 5H), 2.11—2.03 (m, 3H), 2.00—1.92 (m, 
2H), 1.66—1.61 (m, 1H), 1.57—1.50 (m, 1H), 1.35—1.18 (m, 8H), 1.01 (t, J =7.7 Hz, 3H), 0.98 
(t, J =7.5 Hz, 3H), 0.87 (t, J =7.1 Hz, 3H); 
13C-NMR (175 MHz, CDCl3) δ 139.0, 138.4, 138.2, 137.6, 133.5, 128.52, 128.48, 128.1, 128.0, 
128.0, 127.8, 127.8, 127.7, 94.4, 84.2, 81.7, 77.6, 75.5, 75.2, 73.6, 73.3, 70.8, 68.7, 34.3, 31.9, 
29.3, 26.2, 22.8, 21.0, 19.5, 14.52, 14.50, 14.2; 
IR (cm-1) 1503, 1455,1362, 1134, 1026; 
HRMS-ES (m/z) [M+NH4+] calculated: 648.4259 found: 648.4262. 
 
4-((E)-non-2-en-1-yl)cyclohexanone-3,4,6-tri-O-benzyl-α-D-glucopyranoside (7f) was 
synthesized according to general procedure 2-O-[4-((E)-1-((dimethylsilyl)oxy)non-2-en-1-
yl)cyclohexanone]-3,4,6-tri-O-benzyl-β-D-glucopyranosyl fluoride (51 mg, 0.067 mmol), 
titanium tetrafluoride ( 25 mg, 0.20 mmol) and silver tetrafluoroborate (20 mg, 0.10 mmol) were 
stirred for 5 h.  Purification by flash chromatography (6:1 to 1:1  hexanes: ethyl acetate) yielded 
the desired product as separate diastereomers ( 7 mg, 0.010 mmol, minor diastereomer) and (21 
mg, 0.31 mmol, major diastereomer) for a combined yield of 60% with a diastereomeric ratio of 
3:1.  
 
4-((S,E)-non-2-en-1-yl)cyclohexanone-3,4,6-tri-O-benzyl-α-D-
glucopyranoside (7f, entry 4, major diastereomer) 
 
1H-NMR (700 MHz, CDCl3) δ  7.38 (d, J = 7.4 Hz, 2H), 7.36—7.25 
(m, 11H), 7.16—7.14 (m, 2H), 5.61 (dt, J =15.3, 6.8 Hz, 1H), 5.39 
(dd, J =15.3, 8.7 Hz, 1H), 4.99 (d, J =3.7 Hz, 1H), 4.91 (A of AB, J = 
11.2 Hz, 1H), 4.88 (B of AB, J =11.2 Hz, 1H), 4.81 (d, J =10.6 Hz, 1H), 4.64 (d, J =12.1 Hz, 
1H), 4.49 (d, J = 10.9 Hz, 1H), 4.48 (d, J = 12.2 Hz, 1H), 3.86—3.80 (m, 2H), 3.76—3.65 (m, 
4H), 3.54 (dd, J =10.5, 2.0 Hz, 1H), 2.43—2.37 (m, 2H), 2.34—2.27 (m, 2H), 2.18—2.12 (m, 
1H), 2.02—1.91 (m, 5H), 1.48—1.40 (m, 2H), 1.36—1.21 (m, 8H), 0.88 (t, J =7.1 Hz, 3H),  
 
13C-NMR (175 MHz, CDCl3) δ  211.8, 138.8, 138.3, 138.1, 135.2, 128.7, 128.64, 128.58, 128.3, 
128.2, 128.14, 128.12, 128.0, 127.9, 98.7, 84.1, 83.4, 77.8, 75.5, 75.3, 73.8, 73.4, 71.0, 68.3, 
41.0, 40.7, 32.5, 31.9, 29.3, 29.1, 28.8, 28.3, 22.8, 14.3; 
IR (cm-1) 1716, 1455, 1130, 1074, 1052, 1033; 
HRMS-ES (m/z) [M+Na+] calculated: 693.3762, found 693.3759. 
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4-((R,E)-non-2-en-1-yl)cyclohexanone-3,4,6-tri-O-benzyl-α-D-
glucopyranoside (entry 4, minor diastereomer) 
 
1H-NMR (700 MHz, CDCl3) δ 7.39 (d, J = 7.3 Hz, 2H), 7.34—7.25 
(m, 11H), 7.16—7.13 (m, 2H), 5.69 (dt, J = 15.2, 6.9 Hz, 1H), 5.22 
(dd, J = 15.5, 9.0 Hz, 1H), 5.02 (d, J = 3.4 Hz, 1H), 4.95 (d, J = 11.1 
Hz, 1H), 4.86 (d, J = 11.1 Hz, 1H), 4.82 (d, J = 10.6 Hz, 1H), 4.63 (d, J = 12.1 Hz, 1H), 4.50 (d, 
J = 12.1 Hz, 1H), 4.49 (d, J = 10.6 Hz, 1H), 3.86 (apparent t, J = 8.3 Hz, 1H), 3.78—3.70 (m, 
4H), 3.66 (dd, J = 10.2, 1.5 Hz, 1H), 3.63—3.60 (m, 1H), 2.44—2.35 (m, 2H), 2.33—2.27 (m, 
2H), 2.26—2.20 (m, 1H), 2.09—1.90 (m, 5H), 1.48—1.33 (m, 4H), 1.32—1.23 (m, 6H), 0.88 (t, 
J = 7.0 Hz, 3H);   
13C-NMR (175 MHz, CDCl3) δ 211.9, 138.93, 138.91, 138.2, 138.1, 128.67, 128.65, 128.62, 
128.3, 128.12, 128.10, 127.98, 127.98, 127.91, 126.7, 94.4, 83.9, 80.4, 77.6, 75.6, 75.4, 73.8, 
73.0, 71.3, 68.7, 40.7, 40.64, 40.57, 32.6, 31.8, 29.34, 29.28, 29.1, 29.0, 22.8, 14.3; 
IR (cm-1) 1717, 1456, 1132, 1068, 1029; 
HRMS-ES (m/z) [M+Na+] calculated: 693.3762; found 693.3757. 
 
 
((E)-1-cyclohexyl-10-hydroxy-10-methylundec-2-en-1-yl)-3,4,6-tri-O-benzyl-α-D-
glucopyranoside (7g) was synthesized according to general procedure. 2-O-[(E)-11-
((dimethylsilyl)oxy)-11-cyclohexyl-2-methylundec-9-en-2-ol]-3,4,6-tri-O-benzyl-β-D-
glucopyranosyl fluoride (63 mg, 0.080 mmol), titanium tetrafluoride ( 30 mg, 0.24 mmol) and 
silver tetrafluoroborate (24 mg, 0.12 mmol) were stirred for 13 h.  Rough purification by flash 
chromatography (3:1 hexanes:acetone) yielded the desired product as a colorless oil as a mixture 
of separable diastereomers contaminated with 3,4,6-tri-O-benzyl α-D-glucosyl fluoride.  1H 
NMR analysis revealed a diastereomeric ratio of 5.6:1 (S:R).  HPLC purification on a ZorbaxRx-
Sil column (1.6% iPrOH in hexanes) yielded the minor diastereomer (3.7 mg, 0.005 mmol) and 
the major diastereomer contaminated with 22% 3,4,6-tri-O-benzyl α-D-glucosyl fluoride (21 mg, 
0.029 mmol) for a combined yield of 43%. 
 
((S,E)-1-cyclohexyl-10-hydroxy-10-methylundec-2-en-1-yl)- 3,4,6-
tri-O-benzyl- α  -D-glucopyranoside (7g, entry 5, major 
diastereomer) 
 
1H NMR (700 MHz, CDCl3) δ 7.38 (d, J =7.4 Hz, 2H), 7.35—7.24 (m, 
11H), 7.13 (d, J =7.0 Hz, 2H), 5.53 (dt, J =15.3, 6.7 Hz, 1H), 5.35 (dd, 
J =15.3, 8.4 Hz, 1H), 4.96 (d, J =3.6 Hz, 1H), 4.95 (d, J =11.1 Hz, 
1H), 4.83 (d, J =11.1 Hz, 1H), 4.80 (d, J =10.6 Hz, 1H), 4.63 (d, J =12.3 Hz, 1H), 4.47—4.45 
(m, 2H), 3.80 (d, J =9.9 Hz, 1H), 3.74—3.62 (m, 5H), 3.53 (d, J =10.4 Hz, 1H), 2.02—1.92 (m, 
3H), 1.78 (d, J =12.9 Hz, 1H), 1.71 (t, J =14.1 Hz, 2H), 1.67—1.61 (m, 2H), 1.49—1.41 (m, 
3H), 1.36—1.24 (m, 10H), 1.19 (s, 6H), 1.15—1.07 (m, 1H), 0.98—0.81 (m, 3H); 
13C NMR (175 MHz, CDCl3) δ 139.0, 138.4, 138.1, 133.9, 129.2, 128.54, 128.53, 128.5, 128.2, 
128.07, 128.03, 127.9, 127.81, 127.75, 98.6, 85.5, 83.9, 77.54, 75.45, 75.2, 73.72, 73.66, 71.2, 
70.6, 68.4, 44.1, 42.5, 32.4, 30.1, 29.4, 29.34, 29.30, 28.7, 26.7, 26.2, 24.5 IR (cm-1) 1503, 1459, 
1369, 1130, 1074, 1030. 1000. 910; 
HRMS-ES (m/z) [M+Na+] calculated: 737.4388, found 737.4393. 
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((R,E)-1-cyclohexyl-10-hydroxy-10-methylundec-2-en-1-yl)-3,4,6-
tri-O-benzyl-α-D-glucopyranoside (entry 5, minor diastereomer) 
 
1H NMR (700 MHz, CDCl3) δ 7.39 (d, J =7.3 Hz, 2H), 7.35—7.24 (m, 
11H), 7.15 (d, J =7.8 Hz, 2H), 5.60 (dt, J =15.3, 6.7 Hz, 1H), 5.18 (dd, 
J =15.5, 9.0 Hz, 1H), 4.99 (d, J =3.4 Hz, 1H), 4.97 (d, J =11.0 Hz, 
1H), 4.84 (d, J =10.9 Hz, 1H), 4.82 (d, J =10.6 Hz, 1H), 4.65 (d, J 
=12.1 Hz, 1H), 4.50 (d, J =12.1 Hz, 1H), 4.49 (d, J =10.7 Hz, 1H), 3.85—3.81 (m, 1H), 3.77 
(dd, J =10.6, 3.8 Hz, 1H), 3.74—3.70 (m, 3H), 3.67 (dd, J =10.6, 1.8 Hz, 1H), 3.62 (t, J =9.3 
Hz, 1H), 2.19 (d, J =9.0 Hz, 1H), 2.05 (q, J =6.8 Hz, 2H), 1.91 (d, J =12.6 Hz, 1H), 1.71 
(apparent t, J =13.5 Hz, 2H), 1.66—1.61 (m, 2H), 1.58—1.55 (m, 1H), 1.50—1.43 (m, 3H), 
1.40—1.24 (m, 10H), 1.2 (s, 6H), 1.16—1.08 (m, 1H), 0.95—0.87 (m, 2H); 
13C NMR (175 MHz, CDCl3) δ 139.0, 138.4, 138.1, 133.9, 129.2, 128.53, 128.53, 128.49, 
128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 98.6, 85.5, 83.9, 77.5, 75.4, 75.2, 73.71, 73.65, 71.1, 
70.6, 68.3, 44.1, 42.5, 32.4, 29.9, 29.7, 29.4, 29.31, 29.29, 29.10, 29.08, 26.7, 26.2, 24.5; 
IR (cm-1) 1500, 1455, 1373, 1093, 1045, 880; 
HRMS-ES (m/z) [M+Na+] calculated: 737.4388, found: 737.4396. 
 
 
((E)-1-cyclohexyl-7-hydroxyhept-2-en-1-yl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (7h) 
was synthesized according to general procedure. 2-O-[((E)-7-(((t-butyldimethylsilyl)oxy)-1-
cyclohexylhept-2-en-1-yl)oxy)dimethylsilane]-3,4,6-tri-O-benzyl- β -D-glucopyranosyl fluoride 
(81 mg, 0.097 mmol), titanium tetrafluoride ( 36 mg, 0.29 mmol) and silver tetrafluoroborate (28 
mg, 0.14 mmol) were stirred for 5 h.  Purification by flash chromatography (2:1 
hexanes:acetone) yielded the desired product as a colorless oil as a mixture of separable 
diastereomers. 1H-NMR analysis revealed a diastereomeric ratio of 4.3:1 (S:R)  (35 mg, 0.055 
mmol, 57 %). 
 
((S,E)-1-cyclohexyl-7-hydroxyhept-2-en-1-yl) - 3,4,6-tri-O-benzyl- α  -
D-glucopyranoside (7h, entry 6, major diastereomer) 
 
1H-NMR (700 MHz, CDCl3) δ 7.40 (apparent d, J =7.4 Hz, 2H), 7.34—
7.25 (m, 11H), 7.15—7.14 (m, 2H), 5.54 (dt, J =15.3, 6.8 Hz, 1H), 5.38 
(dd, J =15.5, 8.6 Hz, 1H), 4.967 (d, J =3.8 Hz, 1H), 4.965 (d, J =11.0 Hz, 
1H), 4.85 (d, J =11.2 Hz, 1H), 4.81 (d, J =10.5 Hz, 1H), 4.63 (d, J =12.2 
Hz, 1H), 4.48 (d, J =10.5 Hz, 1H), 4.47 (d, J =12.2 Hz, 1H), 3.82 (dt, J 
=9.9, 2.5 Hz, 1H), 3.74—7.64 (m, 5H), 3.59 (apparent t, J =5.8 Hz, 2H), 3.55 (dd, J =10.7, 1.9 
Hz, 1H), 2.02—1.98 (m, 3H), 1.79 (d, J =12.6 Hz, 1H), 1.75—1.71 (m, 2H), 1.65 (apparent t, J 
=11.7 Hz, 2H), 1.55—1.46 (m, 3H), 1.43—1.39 (m, 2H), 1.34 (t, J =5.4 Hz, 1H), 1.23—1.10 
(m, 3H), 0.98—0.87 (m, 2H); 
13C-NMR (175 MHz, CDCl3) δ 138.9, 138.3, 138.1, 133.6, 129.6, 128.49, 128.54, 128.50, 
128.2, 128.08, 128.05 127.9, 127.8, 127.7, 98.4, 85.3, 83.8, 77.5, 75.4, 75.3, 73.7, 73.6, 70.7, 
68.4, 62.9, 42.4, 32.4, 32.1, 29.3, 28.7, 26.6, 26.2, 25.3; 
IR (cm-1) 1500, 1459, 1362, 1216, 1138, 1056, 1030, 996, 918; 
HRMS-ES (m/z) [M+Na+] calculated: 667.3605,  found 667.3610. 
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((R,E)-1-cyclohexyl-7-hydroxyhept-2-en-1-yl)-3,4,6-tri-O-benzyl-α-D-
glucopyranoside (entry 6, minor diastereomer) 
 
1H-NMR (700 MHz, CDCl3) δ 7.40 (apparent d, J =6.9 Hz, 2H), 7.35—
7.30 (m, 6H), 7.30—7.26 (m, 5H), 7.15—7.14 (m, 2H), 5.61 (dt, J =15.4, 
6.9 Hz, 1H), 5.21 (dd, J =15.4, 9.0 Hz, 1H), 4.99 (d, J =3.1 Hz, 1H), 4.97 
(d, J =11.0 Hz, 1H), 4.84 (d, J =11.2 Hz, 1H), 4.82 (d, J =10.8 Hz, 1H), 
4.65 (d, J =12.1 Hz, 1H), 4.50 (d, J =11.9 Hz, 1H), 4.49 (d, J =10.6 Hz, 1H), 3.83 (ddd, J =10.0, 
3.4, 2.1 Hz, 1H), 3.78 (dd, J =10.6, 3.7 Hz, 1H), 3.73—7.69 (m, 3H), 3.67 (dd, J =10.5, 1.9 Hz, 
1H), 3.65—3.61 (m, 3H), 2.10—2.06 (m, 3H), 1.91 (d, J =12.5 Hz, 1H), 1.72 (apparent t, J 
=13.6 Hz, 2H), 1.64 (apparent t, J =11.9 Hz, 2H), 1.59—1.55 (m, 2H), 1.49—1.40 (m, 4H), 
1.23—1.11 (m, 3H), 0.94—0.86 (m, 2H); 
13C-NMR (175 MHz, CDCl3) δ 139.0, 138.3, 138.1, 137.0, 128.6, 128.5, 128.5, 128.3, 128.1, 
128.0, 127.9, 127.8, 127.7, 94.3, 84.0, 81.9, 77.5, 75.5, 75.3, 73.6, 73.2, 70.9, 68.6, 62.8, 42.2, 
32.2, 32.1, 29.7, 29.3, 26.6, 26.2, 26.0, 25.3; 
IR (cm-1) 1503, 1451, 1358, 1142, 1071, 1026, 888; 
HRMS-ES (m/z) [M+Na+] calculated: 667.3605;  found 667.3606. 
 
(E)-methyl-7-cyclohexylhept-5-enoate-3,4,6-tri-O-benzyl-α-D-glucopyranoside (7i) 
was synthesized according to general procedure 2.  2-O-[(E)-Methyl-7-((dimethylsilyl)oxy)-7-
cyclohexylhept-5-enoate]- 3,4,6-tri-O-benzyl-β-D-glucopyranosyl fluoride (70 mg, 0.094 mmol), 
titanium tetrafluoride ( 34 mg, 0.28 mmol) and silver tetrafluoroborate (27 mg, 0.14 mmol) were 
stirred for 5 h.  Purification by flash chromatography (5:1 hexanes:acetone to 2:1 
hexanes:acetone) yielded the desired product as a colorless oil as a mixture of separable 
diastereomers. 1H NMR analysis revealed a diastereomeric ratio of 4.2:1 (S:R) (32 mg, 0.049 
mmol, 52 %). 
 
(S,E)-methyl-7-cyclohexylhept-5-enoate-3,4,6-tri-O-benzyl-α-D-
glucopyranoside (7i, entry 7, major diastereomer) 
 
1H-NMR (700 MHz, CDCl3) δ  7.39 (d, J =7.4 Hz, 2H), 7.34—7.25 
(m, 11H), 7.15—7.14 (m, 2H), 5.52 (dt, J =15.3, 6.7 Hz, 1H), 5.40 (dd, 
J =15.4, 8.5 Hz, 1H), 4.96 (d, J =11.2 Hz, 1H), 4.95 (d, J =3.7 Hz, 
1H), 4.85 (d, J =11.2 Hz, 1H), 4.81 (d, J =10.6 Hz, 1H), 4.63 (d, J 
=12.1 Hz, 1H), 4.48 (d, J =10.6 Hz, 1H), 4.47 (d, J =12.1 Hz, 1H), 3.80 (dt, J =10.0, 2.6 Hz, 
1H), 3.75—3.54 (m, 8H), 3.55 (dd, J =10.6, 2.0 Hz, 1H), 2.29 (t, J =7.5 Hz, 2H), 2.05—1.96 (m, 
3H), 1.79 (d, J =12.7 Hz, 1H), 1.75—1.62 (m, 6H), 1.52—1.51 (m, 1H), 1.26—1.09 (m, 3H), 
0.99—9.88 (m, 2H); 
13C-NMR (175 MHz, CDCl3) δ 174.1, 138.9, 138.4, 138.1, 132.5, 130.3, 128.52, 128.48, 128.2, 
128.08, 128.05, 127.9, 127.8, 127.7, 98.6, 85.3, 83.8, 77.5, 75.4, 75.2, 73.6, 70.7, 68.4, 51.6, 
42.4, 33.6, 31.7, 29.3, 28.7, 26.6, 26.2, 24.5; 
IR  (cm-1) 1738, 1500, 1459, 1365, 1138, 1067, 1052; 
HRMS-ES (m/z) [M+Na+] calculated: 695.3554 found 695.3563. 
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(R,E)-methyl 7-cyclohexylhept-5-enoate - 3,4,6-tri-O-benzyl- α  -D-
glucopyranoside (entry 7, minor diastereomer) 
 
1H-NMR (700 MHz, CDCl3) δ 7.40 (d, J =7.2 Hz, 2H), 7.35—7.26 
(m, 11H), 7.16—7.15 (m, 2H), 5.60 (dt, J =15.3, 6.8 Hz, 1H), 5.23 
(dd, J =15.3, 8.9 Hz, 1H), 4.98 (d, J =11.2 Hz, 1H), 4.97 (d, J =3.4 
Hz, 1H), 4.84 (d, J =11.2 Hz, 1H), 4.83 (d, J =10.6 Hz, 1H), 4.65 (d, J 
=12.1 Hz, 1H), 4.51 (d, J =12.1 Hz, 1H), 4.50 (d, J =10.6 Hz, 1H), 3.82 (ddd, J =10.0, 3.6, 2.0 
Hz, 1H), 3.77 (dd, J =10.6, 3.9 Hz, 1H), 3.75—3.70 (m, 3H), 3.69—3.66 (m, 4H), 3.62 (t, J =9.7 
Hz, 1H), 2.31 (t, J =7.5 Hz, 2H), 2.10 (q, J =7.0 Hz, 2H), 2.03 (d, J =9.2 Hz, 1H), 1.90 (d, J 
=12.8 Hz, 1H), 1.75—1.70 (m, 4H), 1.62 (apparent t, J =12.8 Hz, 2H), 1.50—1.44 (m, 1H), 
1.26—1.10 (m, 3H), 0.96—0.88 (m, 2H); 
13C-NMR (175 MHz, CDCl3) δ 174.0, 139.0, 138.3, 138.2, 136.0, 128.7, 128.53, 128.51, 
128.49, 128.2, 128.0, 128.0, 127.9, 127.8, 127.7, 94.3, 84.0, 81.6, 77.6, 75.5, 75.3, 73.6, 73.2, 
71.0, 68.7, 51.7, 42.2, 33.5, 31.7, 29.7, 29.3, 26.6, 26.2, 26.0, 24.5; 
IR (cm-1) 1742, 1459, 1369, 1138, 1063, 1033, 996; 
HRMS-ES (m/z) [M+NH4+] calculated: 695.3554 found 685.3560. 
 
 
(2-cyclohexyl-1-phenylallyl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (7j)  
 
Compound 7j was synthesized according to general procedure. 2-O-[(E)-
Methyl-7-((dimethylsilyl)oxy)-7-cyclohexylhept-5-enoate]- 3,4,6-tri-O-
benzyl- β -D-glucopyranosyl fluoride (73 mg, 0.10 mmol), titanium 
tetrafluoride ( 37 mg, 0.30 mmol) and silver tetrafluoroborate (29 mg, 0.15 
mmol) were stirred for 5 h.  Purification by flash chromatography (7:1 hexanes: acetone to 4:1 
hexanes acetone) yielded the desired product as a colorless oil as a mixture of separable 
diastereomers. 1H-NMR analysis revealed a diastereomeric ratio of 1.1:1  (38 mg, 0.059 mmol, 
59 %). 
 
7j-1 (first eluting diastereomer): 
1H-NMR (700 MHz, CDCl3) δ 7.40 (apparent d, J =7.2 Hz, 2H), 7.35—7.25 (m, 16H), 7.12—
7.11 (m, 2H), 5.33 (s, 1H), 5.14 (s, 1H), 5.13 (s, 1H), 5.11 (d, J =3.3 Hz, 1H), 4.97 (d, J =11.0 
Hz, 1H), 4.85 (d, J =11.1 Hz, 1H), 4.79 (d, J =10.5 Hz, 1H), 4.611 (d, 1H), 4.47—4.46 (m, 2H), 
3.79—3.77 (m, 2H), 3.68—3.62 (m, 3H), 3.49 (d, J =8.8 Hz, 1H), 2.08 (d, J =9.1 Hz, 1H), 
1.70—1.57 (m, 4H), 1.52 (d, J =14.1 Hz, 1H), 1.26—0.97 (m, 6H); 
13C-NMR (175 MHz, CDCl3) δ 152.8, 140.0, 138.9, 138.2, 138.0, 128.6, 128.5, 128.49, 128.3, 
128.24, 128.18, 128.05, 127.98, 127.96, 127.91, 127.81, 127.80, 127.5, 111.3, 96.5, 83.8, 80.6, 
77.6, 75.6, 75.3, 73.5, 73.4, 70.8, 68.4, 40.2, 34.4, 32.7, 26.9, 26.8, 26.3; 
IR (cm-1) 1496, 1459, 1365, 1134, 1054, 1045, 1015, 918; 
HRMS-ES (m/z) [M+NH4+] calculated: 666.3789; found 666.3790. 
 
7j-2 (second eluting diastereomer): 
1H-NMR (700 MHz, CDCl3) δ  7.39 (apparent d, J =7.2 Hz, 2H), 7.36—7.26 (m, 16H), 7.17—
7.16 (m, 2H), 5.22 (s, 1H), 5.12 (s, 1H), 4.97 (d, J =11.2 Hz, 1H), 4.96 (s, 1H), 4.86 (d, J =11.2 
Hz, 1H), 4.84 (d, J =10.8 Hz, 1H), 4.81 (d, J =4.1 Hz, 1H), 4.66 (d, J =12.0 Hz, 1H), 4.52 (d, J 
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=12.0 Hz, 1H), 4.50 (d, J =10.7 Hz, 1H), 3.89 (ddd, J =10.1, 3.7, 1.9 Hz, 1H), 3.81 (t, J =9.2 
Hz, 1H), 3.78 (dd, J =10.7, 4.0 Hz, 1H), 3.70 (dd, J =10.7, 1.9 Hz, 1H), 3.68—3.61 (m, 2H), 
1.89 (d, J =9.5 Hz, 1H), 1.71—1.56 (m, 5H), 1.51 (d, J =12.9 Hz, 1H), 1.26—1.20 (m, 5H); 
13C-NMR (175 MHz, CDCl3) δ 154.3, 139.1, 138.9, 138.3, 138.1, 128.6, 128.55, 128.51, 128.3, 
128.20, 128.18, 128.1, 128.0, 127.9, 127.82, 127.80, 108.6, 95.5, 83.8, 79.1, 77.5, 75.5, 75.3, 
73.6, 73.2, 71.2, 68.6, 40.8, 34.0, 32.5, 29.9, 26.9, 26.8; 
IR (cm-1) 1503, 1459, 1358, 1134, 1071, 1056, 1030, 903; 
HRMS-ES (m/z) [M+NH4 +] calculated: 666.3789. found 666.3790. 
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